Aclarion Inc. enrolled the first patient in its CLARITY trial, aimed at assessing the impact of its Nociscan technology on surgical treatments for chronic low back pain. The initial participant was enrolled at the Texas Back Institute, recognized for its advancements in spine care. The CLARITY trial is a randomized clinical study designed to evaluate…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here